Advertisement

Current Pharmacology Reports

, Volume 5, Issue 1, pp 68–78 | Cite as

Epigenetic Effects of Essential Fatty Acids

  • Andy T. Y. Lau
  • Fei-Yuan Yu
  • Yan-Ming XuEmail author
Epigenetics (ATY Lau, Section Editor)
  • 16 Downloads
Part of the following topical collections:
  1. Topical Collection on Epigenetics

Abstract

Purpose of Review

In this review, the recent knowledge regarding the epigenetic effects of the four most important dietary fatty acids will be discussed.

Recent Findings

Besides as important sources of fuel for sustaining life, fatty acids are important biomolecules/precursors involved in diverse cellular activities. Insufficient amount of fatty acids present in the body, especially for those essential polyunsaturated fatty acids (PUFAs) which cannot be synthesized (alpha-linolenic acid and linoleic acid)/are inefficiently synthesized (eicosapentaenoic acid and docosahexaenoic acid) by the body, could lead to various human diseases and developmental abnormities. The biological roles of these four essential PUFAs have been extensively studied and reviewed throughout the last decades, e.g., biosynthesis of long-chain PUFAs and eicosanoids, anti-inflammation, cardiovascular protection, inhibition of cancer cell proliferation, anti-metastasis, anti-angiogenesis, and regulation of cancer cell death; interestingly, it has been shown more recently that some of the above attributes could be explained by virtue of PUFAs’ influence on gene activities involving DNA methylation/demethylation, histone modifications, and non-coding RNA expression.

Summary

Essential PUFAs are important biomolecules that mediate epigenetic control of gene expressions; therefore, understanding more about the epigenetic effects associated with these dietary fatty acids are crucial to finding ways for improving human health.

Keywords

Epigenetics Polyunsaturated fatty acids Alpha-linolenic acid Eicosapentaenoic acid Docosahexaenoic acid Linoleic acid 

Notes

Acknowledgments

Due to space constraints, it has been necessary to cite recent articles wherever possible; our sincere apologies to the hundreds of authors whose primary contributions are therefore not listed. We would like to thank members of the Lau and Xu laboratory for critical reading of this manuscript.

Funding Information

This work was supported by the grants from the National Natural Science Foundation of China (Nos. 31271445 and 31771582), the Science and Technology Planning Project of Guangdong Province of China (No. 2016A020215144), the Guangdong Natural Science Foundation of China (No. 2017A030313131), the “Thousand, Hundred, and Ten” project of the Department of Education of Guangdong Province of China (No. 124), the Basic and Applied Research Major Projects of Guangdong Province of China (2017KZDXM035), the Colleges and Universities Innovation Project of Guangdong Province of China (Nos. 2016KTSCX041 and 2016KTSCX042), and the “Yang Fan” Project of Guangdong Province of China (Andy T. Y. Lau-2016; Yan-Ming Xu-2015).

Compliance With Ethical Standards

Conflict of Interest

The authors have declared no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

  1. 1.
    Garrett RH, Grisham CM. Biochemistry. 6th ed: Cengage Learning; 2016.Google Scholar
  2. 2.
    Duplus E, Glorian M, Forest C. Fatty acid regulation of gene transcription. J Biol Chem. 2000;275(40):30749–52.CrossRefGoogle Scholar
  3. 3.
    Wakil SJ, Abu-Elheiga LA. Fatty acid metabolism: target for metabolic syndrome. J Lipid Res. 2009;50(Suppl):S138–43.  https://doi.org/10.1194/jlr.R800079-JLR200.CrossRefGoogle Scholar
  4. 4.
    Currie E, Schulze A, Zechner R, Walther TC, Farese RV Jr. Cellular fatty acid metabolism and cancer. Cell Metab. 2013;18(2):153–61.  https://doi.org/10.1016/j.cmet.2013.05.017.CrossRefGoogle Scholar
  5. 5.
    Los DA, Murata N. Structure and expression of fatty acid desaturases. Biochim Biophys Acta. 1998;1394(1):3–15.CrossRefGoogle Scholar
  6. 6.
    Hastings N, Agaba M, Tocher DR, Leaver MJ, Dick JR, Sargent JR, et al. A vertebrate fatty acid desaturase with Delta 5 and Delta 6 activities. Proc Natl Acad Sci U S A. 2001;98(25):14304–9.  https://doi.org/10.1073/pnas.251516598.CrossRefGoogle Scholar
  7. 7.
    National Center for Biotechnology Information. PubChem Compound Database; CID=444899, https://pubchem.ncbi.nlm.nih.gov/compound/444899.
  8. 8.
    Jump DB. The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem. 2002;277(11):8755–8.CrossRefGoogle Scholar
  9. 9.
    Jump DB, Depner CM, Tripathy S. Omega-3 fatty acid supplementation and cardiovascular disease. J Lipid Res. 2012;53(12):2525–45.  https://doi.org/10.1194/jlr.R027904.CrossRefGoogle Scholar
  10. 10.
    Jing K, Wu T, Lim K. Omega-3 polyunsaturated fatty acids and cancer. Anti Cancer Agents Med Chem. 2013;13(8):1162–77.CrossRefGoogle Scholar
  11. 11.
    Gu Z, Shan K, Chen H, Chen YQ. N-3 polyunsaturated fatty acids and their role in cancer chemoprevention. Curr Pharmacol Rep. 2015;1(5):283–94.CrossRefGoogle Scholar
  12. 12.
    Innes JK, Calder PC. Omega-6 fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids. 2018;132:41–8.  https://doi.org/10.1016/j.plefa.2018.03.004.CrossRefGoogle Scholar
  13. 13.
    Saini RK, Keum YS. Omega-3 and omega-6 polyunsaturated fatty acids: dietary sources, metabolism, and significance - a review. Life Sci. 2018;203:255–67.  https://doi.org/10.1016/j.lfs.2018.04.049.CrossRefGoogle Scholar
  14. 14.
    Xu YM, Du JY, Lau AT. Posttranslational modifications of human histone H3: an update. Proteomics. 2014;14(17–18):2047–60.  https://doi.org/10.1002/pmic.201300435.CrossRefGoogle Scholar
  15. 15.
    Xu YM, Yu FY, Lau ATY. Discovering epimodifications of the genome, transcriptome, proteome, and metabolome: the quest for conquering the uncharted epi(c) territories. Curr Pharmacol Rep. 2017;3(5):286–93.  https://doi.org/10.1007/s40495-017-0103-4.CrossRefGoogle Scholar
  16. 16.
    Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56(8):365–79.CrossRefGoogle Scholar
  17. 17.
    Marventano S, Kolacz P, Castellano S, Galvano F, Buscemi S, Mistretta A, et al. A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: does the ratio really matter? Int J Food Sci Nutr. 2015;66(6):611–22.  https://doi.org/10.3109/09637486.2015.1077790.CrossRefGoogle Scholar
  18. 18.
    National Center for Biotechnology Information. PubChem Compound Database; CID=5280934, https://pubchem.ncbi.nlm.nih.gov/compound/5280934.
  19. 19.
    Niculescu MD, Lupu DS, Craciunescu CN. Perinatal manipulation of alpha-linolenic acid intake induces epigenetic changes in maternal and offspring livers. FASEB J. 2013;27(1):350–8.  https://doi.org/10.1096/fj.12-210724.CrossRefGoogle Scholar
  20. 20.
    He F, Lupu DS, Niculescu MD. Perinatal alpha-linolenic acid availability alters the expression of genes related to memory and to epigenetic machinery, and the Mecp2 DNA methylation in the whole brain of mouse offspring. Int J Dev Neurosci. 2014;36:38–44.  https://doi.org/10.1016/j.ijdevneu.2014.05.006.CrossRefGoogle Scholar
  21. 21.
    National Center for Biotechnology Information. PubChem Compound Database; CID=446284, https://pubchem.ncbi.nlm.nih.gov/compound/446284.
  22. 22.
    Ceccarelli V, Racanicchi S, Martelli MP, Nocentini G, Fettucciari K, Riccardi C, et al. Eicosapentaenoic acid demethylates a single CpG that mediates expression of tumor suppressor CCAAT/enhancer-binding protein delta in U937 leukemia cells. J Biol Chem. 2011;286(31):27092–102.  https://doi.org/10.1074/jbc.M111.253609.CrossRefGoogle Scholar
  23. 23.
    Ceccarelli V, Nocentini G, Billi M, Racanicchi S, Riccardi C, Roberti R, et al. Eicosapentaenoic acid activates RAS/ERK/C/EBPbeta pathway through H-Ras intron 1 CpG island demethylation in U937 leukemia cells. PLoS One. 2014;9(1):e85025.  https://doi.org/10.1371/journal.pone.0085025.CrossRefGoogle Scholar
  24. 24.
    Ceccarelli V, Valentini V, Ronchetti S, Cannarile L, Billi M, Riccardi C, et al. Eicosapentaenoic acid induces DNA demethylation in carcinoma cells through a TET1-dependent mechanism. FASEB J. 2018;14:fj201800245R.  https://doi.org/10.1096/fj.201800245R.Google Scholar
  25. 25.
    Kim J, Okla M, Erickson A, Carr T, Natarajan SK, Chung S. Eicosapentaenoic acid potentiates brown thermogenesis through FFAR4-dependent up-regulation of miR-30b and miR-378. J Biol Chem. 2016;291(39):20551–62.  https://doi.org/10.1074/jbc.M116.721480.CrossRefGoogle Scholar
  26. 26.
    National Center for Biotechnology Information. PubChem Compound Database; CID=445580, https://pubchem.ncbi.nlm.nih.gov/compound/445580.
  27. 27.
    Lee HS, Barraza-Villarreal A, Hernandez-Vargas H, Sly PD, Biessy C, Ramakrishnan U, et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega-3 PUFA during pregnancy in an intervention study. Am J Clin Nutr. 2013;98(2):480–7.  https://doi.org/10.3945/ajcn.112.052241.CrossRefGoogle Scholar
  28. 28.
    Lee HS, Barraza-Villarreal A, Biessy C, Duarte-Salles T, Sly PD, Ramakrishnan U, et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. Physiol Genomics. 2014;46(23):851–7.  https://doi.org/10.1152/physiolgenomics.00061.2014.CrossRefGoogle Scholar
  29. 29.
    van Dijk SJ, Zhou J, Peters TJ, Buckley M, Sutcliffe B, Oytam Y, et al. Effect of prenatal DHA supplementation on the infant epigenome: results from a randomized controlled trial. Clin Epigenetics. 2016;8:114.  https://doi.org/10.1186/s13148-016-0281-7.CrossRefGoogle Scholar
  30. 30.
    Meng Q, Ying Z, Noble E, Zhao Y, Agrawal R, Mikhail A, et al. Systems nutrigenomics reveals brain gene networks linking metabolic and brain disorders. EBioMedicine. 2016;7:157–66.  https://doi.org/10.1016/j.ebiom.2016.04.008.CrossRefGoogle Scholar
  31. 31.
    Cho Y, Turner ND, Davidson LA, Chapkin RS, Carroll RJ, Lupton JR. Colon cancer cell apoptosis is induced by combined exposure to the n-3 fatty acid docosahexaenoic acid and butyrate through promoter methylation. Exp Biol Med (Maywood). 2014;239(3):302–10.  https://doi.org/10.1177/1535370213514927.CrossRefGoogle Scholar
  32. 32.
    Sadli N, Ackland ML, De Mel D, Sinclair AJ, Suphioglu C. Effects of zinc and DHA on the epigenetic regulation of human neuronal cells. Cell Physiol Biochem. 2012;29(1–2):87–98.  https://doi.org/10.1159/000337590.CrossRefGoogle Scholar
  33. 33.
    Pham TX, Bae M, Lee Y, Park YK, Lee JY. Transcriptional and posttranscriptional repression of histone deacetylases by docosahexaenoic acid in macrophages. J Nutr Biochem. 2018;57:162–9.  https://doi.org/10.1016/j.jnutbio.2018.03.002.CrossRefGoogle Scholar
  34. 34.
    Baselga-Escudero L, Arola-Arnal A, Pascual-Serrano A, Ribas-Latre A, Casanova E, Salvado MJ, et al. Chronic administration of proanthocyanidins or docosahexaenoic acid reverses the increase of miR-33a and miR-122 in dyslipidemic obese rats. PLoS One. 2013;8(7):e69817.  https://doi.org/10.1371/journal.pone.0069817.CrossRefGoogle Scholar
  35. 35.
    Siddesha JM, Valente AJ, Yoshida T, Sakamuri SS, Delafontaine P, Iba H, et al. Docosahexaenoic acid reverses angiotensin II-induced RECK suppression and cardiac fibroblast migration. Cell Signal. 2014;26(5):933–41.  https://doi.org/10.1016/j.cellsig.2014.01.005.CrossRefGoogle Scholar
  36. 36.
    Liu ZH, Yip PK, Adams L, Davies M, Lee JW, Michael GJ, et al. A single bolus of docosahexaenoic acid promotes neuroplastic changes in the innervation of spinal cord interneurons and motor neurons and improves functional recovery after spinal cord injury. J Neurosci. 2015;35(37):12733–52.  https://doi.org/10.1523/JNEUROSCI.0605-15.2015.CrossRefGoogle Scholar
  37. 37.
    Mandal CC, Ghosh-Choudhury T, Dey N, Choudhury GG, Ghosh-Choudhury N. miR-21 is targeted by omega-3 polyunsaturated fatty acid to regulate breast tumor CSF-1 expression. Carcinogenesis. 2012;33(10):1897–908.  https://doi.org/10.1093/carcin/bgs198.CrossRefGoogle Scholar
  38. 38.
    Hannafon BN, Carpenter KJ, Berry WL, Janknecht R, Dooley WC, Ding WQ. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA). Mol Cancer. 2015;14:133.  https://doi.org/10.1186/s12943-015-0400-7.CrossRefGoogle Scholar
  39. 39.
    Gil-Zamorano J, Martin R, Daimiel L, Richardson K, Giordano E, Nicod N, et al. Docosahexaenoic acid modulates the enterocyte Caco-2 cell expression of microRNAs involved in lipid metabolism. J Nutr. 2014;144(5):575–85.  https://doi.org/10.3945/jn.113.189050.CrossRefGoogle Scholar
  40. 40.
    Daimiel-Ruiz L, Klett-Mingo M, Konstantinidou V, Mico V, Aranda JF, Garcia B, et al. Dietary lipids modulate the expression of miR-107, an miRNA that regulates the circadian system. Mol Nutr Food Res. 2015;59(3):552–65.  https://doi.org/10.1002/mnfr.201400616.CrossRefGoogle Scholar
  41. 41.
    Fluckiger A, Dumont A, Derangere V, Rebe C, de Rosny C, Causse S, et al. Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNFalpha. Oncogene. 2016;35(35):4611–22.  https://doi.org/10.1038/onc.2015.523.CrossRefGoogle Scholar
  42. 42.
    Yao L, Han C, Song K, Zhang J, Lim K, Wu T. Omega-3 polyunsaturated fatty acids upregulate 15-PGDH expression in cholangiocarcinoma cells by inhibiting miR-26a/b expression. Cancer Res. 2015;75(7):1388–98.  https://doi.org/10.1158/0008-5472.CAN-14-2561.CrossRefGoogle Scholar
  43. 43.
    Fu Y, Zhen J, Lu Z. Synergetic neuroprotective effect of docosahexaenoic acid and aspirin in SH-Y5Y by inhibiting miR-21 and activating RXRalpha and PPARalpha. DNA Cell Biol. 2017;36(6):482–9.  https://doi.org/10.1089/dna.2017.3643.CrossRefGoogle Scholar
  44. 44.
    National Center for Biotechnology Information. PubChem Compound Database; CID=444899, https://pubchem.ncbi.nlm.nih.gov/compound/5280450.
  45. 45.
    Monastero R, Garcia-Serrano S, Lago-Sampedro A, Rodriguez-Pacheco F, Colomo N, Morcillo S, et al. Methylation patterns of Vegfb promoter are associated with gene and protein expression levels: the effects of dietary fatty acids. Eur J Nutr. 2017;56(2):715–26.  https://doi.org/10.1007/s00394-015-1115-7.CrossRefGoogle Scholar
  46. 46.
    Aslibekyan S, Wiener HW, Havel PJ, Stanhope KL, O'Brien DM, Hopkins SE, et al. DNA methylation patterns are associated with n-3 fatty acid intake in Yup'ik people. J Nutr. 2014;144(4):425–30.  https://doi.org/10.3945/jn.113.187203.CrossRefGoogle Scholar
  47. 47.
    Hoile SP, Clarke-Harris R, Huang RC, Calder PC, Mori TA, Beilin LJ, et al. Supplementation with N-3 long-chain polyunsaturated fatty acids or olive oil in men and women with renal disease induces differential changes in the DNA methylation of FADS2 and ELOVL5 in peripheral blood mononuclear cells. PLoS One. 2014;9(10):e109896.  https://doi.org/10.1371/journal.pone.0109896.CrossRefGoogle Scholar
  48. 48.
    Ma Y, Smith CE, Lai CQ, Irvin MR, Parnell LD, Lee YC, et al. The effects of omega-3 polyunsaturated fatty acids and genetic variants on methylation levels of the interleukin-6 gene promoter. Mol Nutr Food Res. 2016;60(2):410–9.  https://doi.org/10.1002/mnfr.201500436.CrossRefGoogle Scholar
  49. 49.
    Cui T, Hester AG, Seeds MC, Rahbar E, Howard TD, Sergeant S, et al. Impact of genetic and epigenetic variations within the FADS cluster on the composition and metabolism of polyunsaturated fatty acids in prostate cancer. Prostate. 2016;76(13):1182–91.  https://doi.org/10.1002/pros.23205.CrossRefGoogle Scholar
  50. 50.
    Tremblay BL, Guenard F, Rudkowska I, Lemieux S, Couture P, Vohl MC. Epigenetic changes in blood leukocytes following an omega-3 fatty acid supplementation. Clin Epigenetics. 2017;9:43.  https://doi.org/10.1186/s13148-017-0345-3.CrossRefGoogle Scholar
  51. 51.
    Karimi M, Vedin I, Freund Levi Y, Basun H, Faxen Irving G, Eriksdotter M, et al. DHA-rich n-3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study. Am J Clin Nutr. 2017;106(4):1157–65.  https://doi.org/10.3945/ajcn.117.155648.CrossRefGoogle Scholar
  52. 52.
    Dimri M, Bommi PV, Sahasrabuddhe AA, Khandekar JD, Dimri GP. Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells. Carcinogenesis. 2010;31(3):489–95.  https://doi.org/10.1093/carcin/bgp305.CrossRefGoogle Scholar
  53. 53.
    Ortega FJ, Cardona-Alvarado MI, Mercader JM, Moreno-Navarrete JM, Moreno M, Sabater M, et al. Circulating profiling reveals the effect of a polyunsaturated fatty acid-enriched diet on common microRNAs. J Nutr Biochem. 2015;26(10):1095–101.  https://doi.org/10.1016/j.jnutbio.2015.05.001.CrossRefGoogle Scholar
  54. 54.
    Dai X, Li M, Geng F. Omega-3 polyunsaturated fatty acids Eicosapentaenoic acid and docosahexaenoic acid enhance dexamethasone sensitivity in multiple myeloma cells by the p53/miR-34a/Bcl-2 axis. Biochemistry (Mosc). 2017;82(7):826–33.  https://doi.org/10.1134/S0006297917070082.CrossRefGoogle Scholar
  55. 55.
    Hirabara SM, Folador A, Fiamoncini J, Lambertucci RH, Rodrigues CF Jr, Rocha MS, et al. Fish oil supplementation for two generations increases insulin sensitivity in rats. J Nutr Biochem. 2013;24(6):1136–45.  https://doi.org/10.1016/j.jnutbio.2012.08.014.CrossRefGoogle Scholar
  56. 56.
    Tyagi E, Zhuang Y, Agrawal R, Ying Z, Gomez-Pinilla F. Interactive actions of Bdnf methylation and cell metabolism for building neural resilience under the influence of diet. Neurobiol Dis. 2015;73:307–18.  https://doi.org/10.1016/j.nbd.2014.09.014.CrossRefGoogle Scholar
  57. 57.
    Huang Q, Wen J, Chen G, Ge M, Gao Y, Ye X, et al. Omega-3 polyunsaturated fatty acids inhibited tumor growth via preventing the decrease of genomic DNA methylation in colorectal cancer rats. Nutr Cancer. 2016;68(1):113–9.  https://doi.org/10.1080/01635581.2016.1115526.CrossRefGoogle Scholar
  58. 58.
    Ramaiyan B, Talahalli RR. Dietary unsaturated fatty acids modulate maternal dyslipidemia-induced DNA methylation and histone acetylation in placenta and fetal liver in rats. Lipids. 2018;53(6):581–8.  https://doi.org/10.1002/lipd.12074.CrossRefGoogle Scholar
  59. 59.
    Isaac AR, da Silva EAN, de Matos RJB, Augusto RL, Moreno GMM, Mendonça IP, et al. Low omega-6/omega-3 ratio in a maternal protein-deficient diet promotes histone-3 changes in progeny neural cells and favors leukemia inhibitory factor gene transcription. J Nutr Biochem. 2018;55:229–42.  https://doi.org/10.1016/j.jnutbio.2018.02.004.CrossRefGoogle Scholar
  60. 60.
    Zheng Z, Ge Y, Zhang J, Xue M, Li Q, Lin D, et al. PUFA diets alter the microRNA expression profiles in an inflammation rat model. Mol Med Rep. 2015;11(6):4149–57.  https://doi.org/10.3892/mmr.2015.3318.CrossRefGoogle Scholar
  61. 61.
    Amaral CL, Crisma AR, Masi LN, Martins AR, Hirabara SM, Curi R. DNA methylation changes induced by a high-fat diet and fish oil supplementation in the skeletal muscle of mice. J Nutrigenet Nutrigenomics. 2014;7(4–6):314–26.  https://doi.org/10.1159/000381777.CrossRefGoogle Scholar
  62. 62.
    Fan C, Sun W, Fu H, Dong H, Xia L, Lu Y, et al. Dietary ratios of N-6/N-3 polyunsaturated fatty acids during maternal pregnancy affect hippocampal neurogenesis and apoptosis in mouse offspring. Nutr Hosp. 2015;32(3):1170–9.  https://doi.org/10.3305/nh.2015.32.3.9259.Google Scholar
  63. 63.
    Tsoukas MA, Ko BJ, Witte TR, Dincer F, Hardman WE, Mantzoros CS. Dietary walnut suppression of colorectal cancer in mice: mediation by miRNA patterns and fatty acid incorporation. J Nutr Biochem. 2015;26(7):776–83.  https://doi.org/10.1016/j.jnutbio.2015.02.009.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Laboratory of Cancer Biology and Epigenetics, Department of Cell Biology and GeneticsShantou University Medical CollegeShantouPeople’s Republic of China

Personalised recommendations